Evidence map›Paper›PMID 41270865›Full record

ReviewClinical medicine (London, England)2025

An overview of paediatric autoimmune and genetic cholestatic liver disease for the adult physician.

Vikram Bains, Deepak Joshi

Abstract readReview
In one paragraph

Review in Clinical medicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vikram BainsInstitute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK. Electronic address: vikrambains@nhs.net.
Deepak JoshiInstitute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paediatric chronic liver diseases are rare, but are increasingly encountered in adult practice as survival improves and more adolescents transition to adult services. Adult physicians must be familiar with these conditions, recognise complications and implement high-quality management of these conditions to provide safe, effective care. Autoimmune liver disease in children includes autoimmune hepatitis, autoimmune sclerosing cholangitis and primary sclerosing cholangitis, with distinct serological and clinical profiles. Cholestatic disorders such as progressive familial intrahepatic cholestasis and Alagille syndrome present additional challenges, often impacting multiple organs and requiring multidisciplinary care. Many patients will enter adulthood having undergone liver transplant, requiring long-term immunosuppression and, where relevant, family planning advice. Recognition of extra-hepatic manifestations, metabolic complications and mental health issues is essential to holistic management. This article outlines the key paediatric liver diseases relevant to adult practice, highlighting key elements of care and long-term considerations for this unique and often complex patient population.

Indexed as

Autoimmune DiseasesCholestasis, IntrahepaticHepatitis, AutoimmuneLiver DiseasesAdolescentAdultChildCholangitis, SclerosingHumansAutoimmune hepatitisCholestasisGeneticLiver transplantPaediatric disorders

Identifiers

PMID41270865
PMCPMC12719645

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.